Published in Eur Respir J on August 01, 1994
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med (2009) 2.71
Primary ciliary dyskinesia: current state of the art. Arch Dis Child (2007) 2.51
Exhaled nitric oxide: a new lung function test. Thorax (1996) 1.64
Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation. Thorax (2005) 1.62
Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child (1996) 1.50
Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax (2002) 1.49
Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child (1996) 1.42
The challenges of diagnosing primary ciliary dyskinesia. Proc Am Thorac Soc (2011) 1.16
Primary ciliary dyskinesia, an orphan disease. Eur J Pediatr (2012) 1.14
Genetics and pulmonary medicine. 6. Immotile cilia syndrome: past, present, and prospects for the future. Thorax (1998) 0.97
Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax (2003) 0.95
Effect of measurement conditions on measured levels of peak exhaled nitric oxide. Thorax (1997) 0.94
Nasal nitric oxide in man. Thorax (1999) 0.94
Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol (2015) 0.91
Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy Asthma Proc (2013) 0.86
Unique among ciliopathies: primary ciliary dyskinesia, a motile cilia disorder. F1000Prime Rep (2015) 0.86
Exhaled NO during graded changes in inhaled oxygen in man. Thorax (1997) 0.84
Interferon γ stimulates accumulation of gas phase nitric oxide in differentiated cultures of normal and cystic fibrosis airway epithelial cells. Lung (2012) 0.83
Primary ciliary dyskinesia. Semin Respir Crit Care Med (2015) 0.82
Nitric oxide and asthma. Arch Dis Child (1995) 0.80
[Primary ciliary dyskinesia]. Wien Klin Wochenschr (2009) 0.78
Exercise and NO production: relevance and implications in the cardiopulmonary system. Front Cell Dev Biol (2015) 0.78
Greater nasal nitric oxide output during inhalation: effects on air temperature and water content. Respir Physiol Neurobiol (2008) 0.77
Assessment of airway inflammation with exhaled NO measurement. Hippokratia (2007) 0.77
Primary Ciliary Dyskinesia: An Update on New Diagnostic Modalities and Review of the Literature. Pediatr Allergy Immunol Pulmonol (2014) 0.76
Kartagener's syndrome: review of a case series. Multidiscip Respir Med (2015) 0.75
Statins in Asthma: Potential Beneficial Effects and Limitations. Pulm Med (2015) 0.75
The evolving spectrum of ciliopathies and respiratory disease. Curr Opin Pediatr (2016) 0.75
How has research in the last five years changed my clinical practice? Arch Dis Child (2005) 0.75
Electronic Noses for Well-Being: Breath Analysis and Energy Expenditure. Sensors (Basel) (2016) 0.75
Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia. Expert Opin Orphan Drugs (2014) 0.75
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
Peptidergic neurones. Nature (1980) 3.36
Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J (1993) 3.29
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Greatly increased luminal nitric oxide in ulcerative colitis. Lancet (1994) 2.96
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J (1997) 2.79
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A (1983) 2.64
Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature (1983) 2.57
Intragastric nitric oxide production in humans: measurements in expelled air. Gut (1994) 2.53
Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand (1982) 2.23
Effects of dietary nitrate on oxygen cost during exercise. Acta Physiol (Oxf) (2007) 2.20
Quantitative analysis of bacterial and mammalian proteomes using a combination of cysteine affinity tags and 15N-metabolic labeling. Anal Chem (2001) 2.06
Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res (1984) 2.05
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods (1983) 1.98
Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol (1985) 1.97
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
High nitric oxide production in human paranasal sinuses. Nat Med (1995) 1.90
Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.85
Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis (1988) 1.84
Air pollution involving nitrogen dioxide exposure and wheezing bronchitis in children. Int J Epidemiol (1995) 1.79
Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol Scand (2001) 1.75
Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology (1997) 1.73
Polypeptide-containing neurons in airway smooth muscle. Annu Rev Physiol (1987) 1.70
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett (1983) 1.68
Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies. Acta Physiol Scand Suppl (1981) 1.64
A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett (1984) 1.63
Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation. Thorax (2005) 1.62
Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea. Acta Physiol Scand (1982) 1.59
Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand (1983) 1.59
Pulmonary chemoreflexes elicited by intravenous injection of lactic acid in anesthetized rats. J Appl Physiol (1985) (1996) 1.58
The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock. Gut (1998) 1.53
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides (1984) 1.51
Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs. Acta Physiol Scand (1983) 1.51
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis. Eur Respir J (2002) 1.49
House dust mite sensitization in children and residential characteristics in a temperate region. J Allergy Clin Immunol (1991) 1.47
Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand (1984) 1.45
Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child (1996) 1.42
Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand (1978) 1.42
Pityrosporum orbiculare and atopic eczema. Allergy (1993) 1.42
Bronchial smooth muscle contraction induced by stimulation of capsaicin-sensitive sensory neurons. Acta Physiol Scand (1982) 1.41
Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides (1987) 1.41
Ultrastructural localization of VIP-like immunoreactivity in large dense-core vesicles of 'cholinergic-type' nerve terminals in cat exocrine glands. Neuroscience (1981) 1.41
Cardiac outflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man. Eur Heart J (1995) 1.40
Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release. Neuroscience (1983) 1.40
Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett (1986) 1.38
Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig. Acta Physiol Scand (1984) 1.38
NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J (1999) 1.36
Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept (1985) 1.35
Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res (1995) 1.32
Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. Pulm Pharmacol (1988) 1.30
Breast feeding and allergic diseases in infants-a prospective birth cohort study. Arch Dis Child (2002) 1.30
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol Scand (1988) 1.27
Enkephalin immunoreactive nerve fibres and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neuroscience (1979) 1.26
Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A (1979) 1.26
Enkephalin-like immunoreactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary gland cells. Acta Physiol Scand (1978) 1.26
The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology (2000) 1.26
Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc Natl Acad Sci U S A (1985) 1.24
Indoor viable dust-bound microfungi in relation to residential characteristics, living habits, and symptoms in atopic and control children. J Allergy Clin Immunol (1992) 1.24
Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining. Neuroscience (1979) 1.23
Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience (1986) 1.22
Increased nitric oxide in exhaled air after intake of a nitrate-rich meal. Respir Med (2001) 1.19
Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices. Neurosci Lett (1986) 1.19
Immunohistochemical evidence for a local VIP-ergic neuron system in the adrenal gland of the rat. Acta Physiol Scand (1981) 1.19
Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology (1979) 1.19
Radiographic diagnosis of foreign bodies in the oesophagus. J Laryngol Otol (1978) 1.18
Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol Scand (1984) 1.18
Direct and indirect exposure to pets - risk of sensitization and asthma at 4 years in a birth cohort. Clin Exp Allergy (2003) 1.18
Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain. Acta Physiol Scand (1989) 1.17
Increased IgE antibody responses in rats exposed to tobacco smoke. J Allergy Clin Immunol (1985) 1.16
Calcitonin gene-related peptide (CGRP) and capsaicin-induced stimulation of heart contractile rate and force. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.15
Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.14
Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation. Neurosci Lett (1984) 1.14
Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.14
Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons--functional and pharmacological implications. Prog Brain Res (1986) 1.14
Indoor environmental risk factors in young asthmatics: a case-control study. Arch Dis Child (1995) 1.14
Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamine in some peripheral and central neurons. Acta Physiol Scand (1980) 1.13
Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol (1989) 1.13
Origin of peptide-containing fibers in the inferior mesenteric ganglion of the guinea-pig: immunohistochemical studies with antisera to substance P, enkephalin, vasoactive intestinal polypeptide, cholecystokinin and bombesin. Neuroscience (1983) 1.13
Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide (2001) 1.13
Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg (1991) 1.12
Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest (1985) 1.12
Salivary contribution to exhaled nitric oxide. Eur Respir J (1999) 1.11
Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology (1986) 1.11
Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide. Proc Natl Acad Sci U S A (1981) 1.11
Cellular and subcellular localization of protein I in the peripheral nervous system. Proc Natl Acad Sci U S A (1982) 1.09
Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ Res (1987) 1.08
Distribution and origin of substance P- and neuropeptide Y-immunoreactive nerves in the guinea-pig heart. Cell Tissue Res (1986) 1.08